How We Interpret Thrombosis with Thrombocytopenia Syndrome?Review Published on 2024-05-012024-09-05 Journal: International Journal of Molecular Sciences [Category] update2024, [키워드] antiphospholipid antibody syndrome Disseminated intravascular coagulation hemolytic uremic syndrome heparin-induced thrombocytopenia paroxysmal nocturnal hemoglobinuria Thrombosis with thrombocytopenia syndrome thrombotic microangiopathy Thrombotic thrombocytopenic purpura vaccine-induced immune thrombotic thrombocytopenia [DOI] 10.3390/ijms25094956 PMC 바로가기 [Article Type] Review
The impact of vascular endothelial glycocalyx on the pathogenesis and treatment of disseminated intravascular coagulationReview Article Published on 2023-12-282024-09-05 Journal: Blood coagulation & fibrinolysis : an internationa [Category] update2024, [키워드] ANGPTs/Tie-2 Disseminated intravascular coagulation Endothelial glycocalyx vascular endothelial dysfunction [DOI] 10.1097/MBC.0000000000001257 PMC 바로가기 [Article Type] Review Article
Antithrombin as Therapeutic Intervention against Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation: Lessons Learned from COVID-19-Associated CoagulopathyArticle Published on 2022-10-182022-11-15 Journal: International Journal of Molecular Sciences [Category] 바이오마커, [키워드] activity Anticoagulant Anticoagulants Antithrombin benefit Biomarker Coagulopathies Coagulopathy Combination contributed COVID-19 deficiency differential diagnosis Disseminated intravascular coagulation Establishing Evidence heterogeneous population Intervention lesson Pathogenesis recent Research Scoring scoring system Sepsis sepsis patient significantly specific treatment Treatment [DOI] 10.3390/ijms232012474 PMC 바로가기
Varicella vaccination in India’s universal immunisation program -is it time?Article Published on 2022-10-012023-05-31 Journal: Tropical doctor [Category] 두창, 수두, 홍역, [키워드] acute respiratory distress syndrome Chickenpox Disseminated intravascular coagulation myocarditis necrotizing fasciitis Septic shock [DOI] 10.1177/00494755221107458
Nafamostat Mesylate for Treatment of COVID-19 in Hospitalised Patients: A Structured, Narrative ReviewArticle Published on 2022-10-012022-11-15 Journal: Clinical pharmacokinetics [Category] COVID19(2023년), SARS, 신약개발, 치료제, [키워드] acute respiratory syndrome addition Antithrombotic Antiviral antiviral potency benefit cell line cellular clinical Clinical outcome clinical study clinical trial clinically Coronavirus-2 COVID-19 disease Disseminated intravascular coagulation drug effective Efficacy enzyme human cells human lung hypothesised indication inhibitory concentration intravenous investigated Japan Laboratory mesylate nafamostat Nafamostat mesylate narrative patients with moderate pharmacokinetic protease recruitment Remdesivir repurposing review robust SARS-CoV-2 serine 2 severe COVID-19 TMPRSS2 transmembrane treatment for COVID-19 viral entry [DOI] 10.1007/s40262-022-01170-x PMC 바로가기
Comparison of acute respiratory distress syndrome in patients with COVID-19 and influenza A (H7N9) virus infectionResearch article Published on 2022-09-012022-10-05 Journal: International Journal of Infectious Diseases [Category] 진단, 치료기술, [키워드] acute respiratory distress acute respiratory distress syndrome analyzed ARDS assessment cause clinical clinical feature coagulation disorder coagulation dysfunction COVID-19 death develop died disease disease course Disseminated intravascular coagulation failure H7N9 Hypoxemia illness onset infections Inflammatory Inflammatory response influenza A Liver injury median interval multiple organ dysfunction objective paO2/fiO2 Patient patients with COVID-19 proportion Result SARS-CoV-2 Septic shock severe ARDS susceptible syndrome virus virus infection [DOI] 10.1016/j.ijid.2022.06.053 [Article Type] Research article
Coagulopathy in COVID-19 and anticoagulation clinical trialsReview article Published on 2022-08-012022-10-05 Journal: Best Practice & Research Clinical Haematology [Category] SARS, 바이오마커, 임상, [키워드] acute respiratory disease acute respiratory distress anticoagulation ARDS Asymptomatic CAC caused clinical trial Coagulopathy coronavirus COVID-19 COVID-19 patients develop Disseminated intravascular coagulation Endothelial cell Endotheliitis event feature form global pandemic infected with SARS-CoV-2 knowledge mechanism moderate NETs Other patients with moderate risk severe COVID-19 symptomatic syndrome thrombosis thrombotic event unique Wuhan, China [DOI] 10.1016/j.beha.2022.101377 [Article Type] Review article
Hospitalized COVID-19 Patients with Severe Acute Respiratory Syndrome: A Population-Based Registry Analysis to Assess Clinical Findings, Pharmacological Treatment and Survival중증 급성 호흡기 증후군으로 입원한 COVID-19 환자: 임상 결과, 약리학적 치료 및 생존을 평가하기 위한 인구 기반 레지스트리 분석Article Published on 2022-06-192022-09-12 Journal: Medicina [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome age Antibiotics antimalarial carried clinical Clinical findings Clinical outcome Corticosteroid COVID-19 COVID-19 patient death develop Disseminated intravascular coagulation females hospital hospitalized patient In-hospital incidence male material Medicine Mortality mortality rate Older Patient patients with SARS pharmacological pharmacological treatment predictor predictors Prevalence Probability real-world data registry respiratory SARS-CoV-2 Severe acute respiratory syndrome steroid survival treatment for COVID-19 variable Ventilation with COVID-19 [DOI] 10.3390/medicina58060829 PMC 바로가기 [Article Type] Article
Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedureArticle Published on 2022-05-012022-11-16 Journal: Neuroradiology [Category] 치료기술, [키워드] Ad26.COV2.S Adenovirus-vectored COVID-19 vaccination age antibody anticoagulation artefact bleeding cause cerebral cerebral venous sinus thrombosis ChAdOx1 Clinical sign complexes cortical Course COVID-19 Diagnosis diagnostic Disseminated intravascular coagulation exclusion headache heparin-induced thrombocytopenia immune increases in individual intensity Laboratory magnetic resonance imaging mandatory MRI Neurological symptoms Oxford-AstraZeneca pathogenic Platelet regimen susceptibility Symptom syndrome therapeutic therapy thrombosis thrombotic Thrombus vaccination vaccine-induced immune thrombotic thrombocytopenia venous women [DOI] 10.1007/s00234-022-02914-z PMC 바로가기
COVID-19 associated coagulopathy and thrombosis in cancerResearch article Published on 2022-05-012022-10-05 Journal: Thrombosis research [Category] COVID19(2023년), SARS, 임상, [키워드] adverse outcome amplify anti-cancer treatment Antithrombotic Cancer cancer patient caused clinical study clinically Coagulation Coagulopathy Combination COVID-19 COVID-19 infection COVID-19 vaccination D-dimer disease Disseminated intravascular coagulation effective Efficacy and safety evaluated haematological malignancy hypercoagulable immune response Immune suppression IMPROVE incidence Infection intensity lung cancer management outcome Patient patients Prophylaxis Pulmonary embolism risk Safe SARS-CoV-2 selected seroconversion rate Severe COVID-19 Infection Specific thromboembolic complications thrombosis thrombotic microangiopathy vaccination venous thromboembolic [DOI] 10.1016/j.thromres.2021.12.006 [Article Type] Research article